Brought to you by 
PDL acquires majority stake in Noden
08 Sep 2020
Executive Summary
PDL BioPharma Inc. is acquiring a majority stake in Noden Pharma DAC, a private specialty pharmaceutical company based in Ireland, which was formed in March 2016 to acquire established prescription medicines across various therapeutic areas from global pharma players.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Earnout
- Partial Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
PDL acquires majority stake in Noden
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice